{"product_id":"computational-biology-market-by-services-contract-in-house-application-cellular-biological-simulation-clinical-trials-drug-discovery-disease-modelling-end-use-global-forecast-2023-2030","title":"Computational Biology Market by Services (Contract, In-house), Application (Cellular Biological Simulation, Clinical Trials, Drug Discovery \u0026 Disease Modelling), End-Use - Global Forecast 2023-2030","description":"\u003cp\u003eComputational Biology Market by Services (Contract, In-house), Application (Cellular Biological Simulation, Clinical Trials, Drug Discovery \u0026amp; Disease Modelling), End-Use - Global Forecast 2023-2030\u003cbr\u003e\nThe Computational Biology Market is projected to reach USD 21.01 billion by 2030 from USD 5.26 billion in 2022, at a CAGR of 18.89% during the forecast period.\u003c\/p\u003e\n\n\u003cp\u003eMarket Segmentation \u0026amp; Coverage:\u003c\/p\u003e\n\n\u003cp\u003eThis research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Computational Biology Market.Based on Services, market is studied across Contract and In-house. The Contract commanded largest market share of 67.88% in 2022, followed by In-house.Based on Application, market is studied across Cellular Biological Simulation, Clinical Trials, Drug Discovery \u0026amp; Disease Modelling, Human Body Simulation Software, and Preclinical Drug Development. The Drug Discovery \u0026amp; Disease Modelling commanded largest market share of 34.12% in 2022, followed by Cellular Biological Simulation.Based on End-Use, market is studied across Academics and Commercial. The Commercial commanded largest market share of 92.68% in 2022, followed by Academics.Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East \u0026amp; Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East \u0026amp; Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 39.15% in 2022, followed by Europe, Middle East \u0026amp; Africa.Market Statistics:\u003c\/p\u003e\n\n\u003cp\u003eThe report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.\u003c\/p\u003e\n\n\u003cp\u003eFPNV Positioning Matrix:\u003c\/p\u003e\n\n\u003cp\u003eThe FPNV Positioning Matrix is an indispensable tool for assessing the Computational Biology Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.\u003c\/p\u003e\n\n\u003cp\u003eMarket Share Analysis:\u003c\/p\u003e\n\n\u003cp\u003eThe Market Share Analysis offers invaluable insights into the vendor landscape Computational Biology Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.\u003c\/p\u003e\n\n\u003cp\u003eKey Company Profiles:\u003c\/p\u003e\n\n\u003cp\u003eThe report delves into recent significant developments in the Computational Biology Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Applied Biological Materials Inc., BGI Group, Biomax Informatics AG, Chemical Computing Group Inc., Compugen Ltd., Dassault Systèmes SE, DNAnexus, Inc., DNASTAR, Inc., Eurofins Scientific SE, Genedata AG, Genomatix, Illumina, Inc., Insilico Medicine, Instem Group, Luminex Corporation, Nimbus Discovery Llc, Partek Incorporated, Partek Incorporated by KONE Corporation, PerkinElmer, Inc., ProFound Therapeutics, QIAGEN N.V., Rosa \u0026amp; Co. Llc, Schrodinger, Inc., Simulation Plus Inc., SOPHiA GENETICS, Thermo Fisher Scientific Inc., Waters Corporation, and WuXi NextCODE.\u003c\/p\u003e\n\n\u003cp\u003eThe report offers valuable insights on the following aspects:Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.Competitive Assessment \u0026amp; Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.Product Development \u0026amp; Innovation: Intelligent insights on future technologies, R\u0026amp;D activities, and breakthrough product developments.The report addresses key questions such as:What is the market size and forecast for the Computational Biology Market?Which products, segments, applications, and areas hold the highest investment potential in the Computational Biology Market?What is the competitive strategic window for identifying opportunities in the Computational Biology Market?What are the latest technology trends and regulatory frameworks in the Computational Biology Market?What is the market share of the leading vendors in the Computational Biology Market?Which modes and strategic moves are suitable for entering the Computational Biology Market?\u003c\/p\u003e\n\n\u003cp\u003eNote: PDF \u0026amp; Excel + Online Access - 1 Year\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"October, 2023 \/ 181 Pages \/ MCW16232837","offer_id":47648470892850,"sku":null,"price":5939.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/computational-biology-market-by-services-contract-in-house-application-cellular-biological-simulation-clinical-trials-drug-discovery-disease-modelling-end-use-global-forecast-2023-2030","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}